Biotech Investors & VC Firms in United Kingdom

137 firms in this list, with a median first check of $500K. 8 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
Vesalius Biocapital III Partners SàRL 5 people	Strassen	LU	Series C–Late Stage	$10.8M	+ Add to CRM
Esperante Ventures 2 people	London	GB	Seed–Series A	$540K – $5.4M	+ Add to CRM
ETCapital 2 people	Cambridge	GB	Seed–Series A	$25.4K – $952.5K	+ Add to CRM
European Equity Partners 2 people	London	GB	Series A–Series B	$540K – $10.8M	+ Add to CRM
Longbow Capital LLP 2 people	Norwich	GB	Series C–Late Stage	$1.3M – $12.7M	+ Add to CRM
QUBIS 2 people	Belfast	GB	Seed–Series A	$12.7K – $127K	+ Add to CRM
UK Innovation & Science Seed Fund 2 people	London	GB	Pre-Seed–Series A	$127K – $635K	+ Add to CRM
Korea Investment Partners 1 person	Seoul	KR	Series A–Late Stage	$3M – $10M	+ Add to CRM
AbbVie 1 person	Cambridge	US	Seed–Late Stage	$300K – $3M	+ Add to CRM
Be8 Ventures 1 person	Berlin	DE	Seed–Series A	$2.2M – $10.8M	+ Add to CRM
EMBL Ventures 1 person	Heidelberg	DE	Seed–Late Stage	$108K – $5.4M	+ Add to CRM
Innvotec Ltd. 1 person	London	GB	Series A–Series B	$317.5K – $635K	+ Add to CRM
OMX Ventures 4 people	Lincolnshire	US	Seed–Series A	—	+ Add to CRM
ORI Capital 4 people	—	HK	Series A–Late Stage	—	+ Add to CRM
Rosetta Capital Ltd. 4 people	Haddenham	GB	Series A	—	+ Add to CRM
Aescuvest 3 people	Frankfurt am Main	DE	Seed–Late Stage	—	+ Add to CRM
Cancer Focus 3 people	Shreveport	US	Series A	—	+ Add to CRM
Kelvin Capital 3 people	Glasgow	GB	Seed–Late Stage	—	+ Add to CRM
Longwall Venture Partners LLP 3 people	Thame	GB	Seed–Series A	—	+ Add to CRM
NATO Innovation Fund 3 people	Amsterdam	NL	Seed–Series B	$16.2M	+ Add to CRM
Nucleus Capital 3 people	Berlin	DE	Pre-Seed–Series A	—	+ Add to CRM
Propagator Ventures 3 people	Oslo	NO	Seed–Series A	—	+ Add to CRM
Rockley Group 3 people	Oxford	GB	Growth	—	+ Add to CRM
Supermoon Capital 2 people	Belvedere	US	Pre-Seed–Series A	—	+ Add to CRM